STRATEGIC INVESTMENT MANAGEMENT, LLC - PROGENICS PHARMACEUTICALS IN ownership

PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 116 filers reported holding PROGENICS PHARMACEUTICALS IN in Q3 2016. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.

Quarter-by-quarter ownership
STRATEGIC INVESTMENT MANAGEMENT, LLC ownership history of PROGENICS PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2016$63,00010,0130.04%
Other shareholders

There were no reported owners of PROGENICS PHARMACEUTICALS IN in Q3 2016.

NameSharesValueWeighting ↓
View complete list of PROGENICS PHARMACEUTICALS IN shareholders